Print Page  |  Contact Us  |  Sign In
Lisa Swanson, MD
Share |

Dr. Swanson is a board certified dermatologist. She was born in New Orleans, LA and raised in Scottsdale, AZ. She attended college at the University of Colorado at Boulder, graduating with honors as an English major. After that, she obtained her medical degree from Tulane University School of Medicine in New Orleans. She performed her internship at Mayo Clinic in Scottsdale, AZ and went on to complete her dermatology residency at Mayo Clinic in Rochester, MN. She recently completed a fellowship in pediatric dermatology at Phoenix Children’s Hospital in Arizona.

 

Name That Nubbin!

This lecture will provide an overview of various bumps and spots on the skin in children.

Objectives:

  1. Review treatment options for pyogenic granulomas
  2. Review congenital cysts on the neck
  3. Review treatment options for warts and mollescum

Needs:

  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) or indication(s)
  4. Advances in medical knowledge

References:

  • Mastocytosis. Neonatal and Infant Dermatology. 3rd Ed. pgs. 132-133.
  • Wine Lee et al. Treatment of PGs Using B-Adrenergic Receptor Antagonists. Ped Derm. Vol 31 Issue 2 March/April 2014 pgs. 203-207.
  • Hernandez Martin et al. Nevus Anemicus: A Distinctive Cutaneous Findin in NF type 1. Ped Derm. Vol 32 Issue 3 May/June 2015 pgs. 342-347.

Core Competencies: 2, 3, 4, 5, 6

 

Pediatric Dermatology Update

This lecture will give an overview of new treatments from common pediatric dermatology issues.

 Objectives:

  1. Review new treatment options for pediatric dermatology issues
  2. Review new details about common pediatric rashes
  3. Review JAK inhibitors

Needs:

  1. New advances in dermatologic treatment
  2. New methods of diagnosis or treatment
  3. Availability of new medication(s) or indication(s)
  4. Development of new technology
  5. Advances in medical knowledge

References:

  • Paller et al. Efficacy and Safety of Crisaborole Ointment. JAAD. Vol 75 No 3 pgs. 494-503.
  • Simpson et al. Dupilumab Therapy Provides Clinically Meaningful Improvement. JAAD. Vol 75 No 3 pgs. 506-515.
  • Paller et al. Long-Term Safety and Efficacy of Etanercept in Children and Adolescents with Plaque Psoriasis. JAAD. Vol 74 No 2 pgs. 280-287.

Core Competencies: 2, 3, 4, 5, 6, 7

Disclosures: Speaker for Valeant, Bayer; Advisory Board of Sanofi Regeneron, Amgen, Allergan

Community Search
Sign In
Sign In securely
Calendar
Latest News